Evidence map›Paper›PMID 42339155›Full record

ArticleCase reports in critical care2026

Critical Care Management Considerations in

Jerry Chen, Caleigh Horan, Krishen Wadhwani, Pedro M Dammert, Elizabeth Sophy

Abstract read
In one paragraph

Article in Case reports in critical care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Critical Care Management Considerations inCase reports in critical care · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jerry ChenDepartment of Internal Medicine, San Ysidro Health, San Ysidro, California, USA.ORCID https://orcid.org/0000-0002-7791-5749
Caleigh HoranDepartment of Internal Medicine, San Ysidro Health, San Ysidro, California, USA.
Krishen WadhwaniDepartment of Internal Medicine, San Ysidro Health, San Ysidro, California, USA.
Pedro M DammertDepartment of Internal Medicine, Scripps Mercy Hospital, Chula Vista, California, USA.
Elizabeth SophyDepartment of Internal Medicine, Scripps Mercy Hospital, Chula Vista, California, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Objectives: This article aims to describe the clinical characteristics of hospitalized and critically ill patients with ILAS and providing management considerations for critical care clinicians. Main Outcomes and Measures: Adult patients admitted to Scripps Health from Janurary 1, 2018 to April 1, 2024 were reviewed. Inclusion criteria required radiographic evidence of a liver abscess and cultures (blood or abscess) positive for Results: Six patients had ILAS. Mean age was 54.8 years, no immunosuppression (defined as underlying malignancy, drug-induced, or chronic infection), 83% had diabetes, 50% were male, and 50% were of Asian ethnicity. Liver abscesses were multilocular (50%), and all had percutaneous catheter drainage. Fifty percent of patients developed distant metastatic infections: emphysematous cystitis, pulmonary septic emboli, complicated parapneumonic pleural effusions, meningitis, ventriculitis, cerebral septic emboli, and endophthalmitis. These patients were younger, male, and had a higher rate of intensive care unit (ICU) admission and mechanical ventilation. Two patients required ICU admission with septic shock, diabetic ketoacidosis, respiratory failure, severe thrombocytopenia, and altered mental status. Conclusions and Relevance: ILAS is an emerging disease that can cause severe critical illness with multiorgan involvement. Early identification of the disease and metastatic infection is essential to provide appropriate treatment. Additionally, ILAS patients require screening for endophthalmitis.

Indexed as

critical illnessendophthalmitisKlebsiella pneumoniaeliver abscessmeningitis

Identifiers

PMID42339155
PMCPMC13284825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.